Search results :

Cefepime

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J01DE01

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Haemolysis Haemolysis 18.7% x x
Infection Infection 1% - 10% x
Pneumonia Pneumonia 1% - 10% x
Sepsis Septicemia 2% - 10% x
Abdominal infection Abdominal infection 2% - 10% x
Bronchitis Bronchitis 1% - 10% x
Diarrhoea Diarrhoea 1.2% - 3% x x x x x x x x x x x x x x x
Local reaction Local reaction 3% x x x x x x x x x x x x x x x
Blood phosphorus decreased Phosphorus low 2.8% x x x x x x x x x x x
Nausea Nausea 2% x x x x x x x x x x x x x x x
Dermatitis Rash 1.1% - 4% x x x x x x x x x x x x x x x
Rash Rash 1.1% - 4% x x x x x x x x x x x x x x x
Phlebitis Phlebitis 1.3% - 2.9% x x x x x x x x x x x x x x x
Body temperature increased Body temperature increased 1% - 7% x x x x x x x x x x x x x
Headache Headache 1% x x x x x x x x x x x x x x x
Pruritus Pruritus 1% x x x x x x x x x x x x x x x
Vomiting Vomiting 1% x x x x x x x x x x x x x x x
Inflammation Inflammation 0.1% - 0.6% x x x x x x x x x x x x x x x
Agranulocytosis Agranulocytosis postmarketing x x x x x x x x x x x x x x x
Anaphylactic shock Anaphylactic shock postmarketing x x x x x x x x x x x x x x x
Anaemia Anaemia postmarketing x x x x x x x
Aplastic anaemia Aplastic anaemia postmarketing x x x x x x x x x x x x x x x
Haemolytic anaemia Haemolytic anaemia postmarketing x x x x x x x x x x x x x x
Cholestasis Cholestasis postmarketing x x x x x x x x x x x x x x x
Coma Coma postmarketing x x x x x x x x x x x x x x x
Confusional state Confusional state postmarketing x x x x x x x x x x x x x x
Feeling abnormal Confusional state postmarketing x x x x x x x x x x x x x x
Toxic epidermal necrolysis Toxic epidermal necrolysis postmarketing x x x x x x x x x x x x x x x
Erythema multiforme Erythema multiforme postmarketing x x x x x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x
Hallucination Hallucination postmarketing x x x x x x x x x x x x x x x
Haemorrhage Haemorrhage postmarketing x x x x x x x x x x x x x x x
Haemoglobin Haemorrhage postmarketing x x x x x x x x x x x x x x x
Leukopenia Leukopenia postmarketing x x x x x x x x x x x x x x x
Myoclonus Myoclonus postmarketing x x x x x x x x x x x x x x x
Neutropenia Neutropenia postmarketing x x x x x x x x x x x x
Pancytopenia Pancytopenia postmarketing x x x x x x x x x x x x x
Renal failure Renal failure postmarketing x x x x x x x x x x
Renal impairment postmarketing x x x x x x x x x x x
Convulsion Convulsion postmarketing x x x x x x x x x x x x x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x
Thrombocytopenia Thrombocytopenia postmarketing x x x x x x x x x x x x x x x
Urticaria Urticaria postmarketing x x x x x x x x x x x x x x x
Encephalopathy Encephalopathy postmarketing x x x x x x x x x x x x x x x
Stupor Stupor postmarketing x x x x x x x x x x x x x x x
Depressed level of consciousness Stupor postmarketing x x x x x x x x x x x x x x x
Hepatic function abnormal Hepatic function abnormal postmarketing x x x x x x
Altered state of consciousness Consciousness abnormal postmarketing x x x x x x x x x x x x x x
Neurotoxicity Neurotoxicity postmarketing x x x x x x
Nephropathy toxic Nephropathy toxic postmarketing x x x x x x x x x x x x x x x
Status epilepticus Nonconvulsive status epilepticus postmarketing x x x x x x
Liver disorder Hepatic impairment postmarketing x x
Renal impairment Renal impairment postmarketing x x x x x x x x x x x
Abdominal pain Abdominal pain x x x
Gastrointestinal pain Abdominal pain x x x
Candida infection Candida infection x x x
Oral candidiasis x x x x x x x x x x x x x x x
Oral candidiasis Oral candidiasis x x x x x x x x x x x x x x x
Vulvovaginal candidiasis Vaginal moniliasis x
Vulvovaginal mycotic infection Vaginal moniliasis x
Colitis Colitis x x x x x x x x x x x x x x x
Constipation Constipation x x x
Dizziness Dizziness x x x
Dysgeusia Dysgeusia x x x
Dyspnoea Dyspnoea x x x
Eosinophilia Eosinophilia x x x
Extravasation Extravasation x
Hypersensitivity Hypersensitivity x x x x x
Hypocalcaemia Hypocalcaemia x x x
Pain Pain x x x x x x x x x x x x x x x
Paraesthesia Paraesthesia x x x
Pruritus genital Pruritus genital x
Pyelonephritis Pyelonephritis x
Shock Shock x
Erythema Erythema x x x x x x x
Urinary tract infection Urinary tract infection x
Vaginal inflammation Vaginal inflammation x x x x x x x x x x x x x x x
Vaginal infection Vaginal inflammation x x x x x x x x x x x x x x x
Vasodilation procedure Vasodilation x x x
Chills Chills x x x
Hepatic failure Hepatic failure x
Injection site inflammation Injection site inflammation x x x
Blood alkaline phosphatase increased Phosphatase alkaline increased x x x x x x x x x x x x
Prothrombin level increased Prothrombin level increased x x x
Alanine aminotransferase increased Alanine aminotransferase increased x x x x x x x x x x x x
Disability Disability x x x x x x x x x x x
Agitation Excitability x
Muscle mass Muscle mass x
Pneumonia streptococcal Pneumonia due to Streptococcus, group b x
Gastrointestinal disorder Gastrointestinal symptom NOS x x x
Hypercalcaemia Ca++ increased x
Blood potassium increased Potassium increased x
Blood calcium decreased Calcium low x x x x x x x x x x x x x
Pseudomembranous colitis Pseudomembranous colitis x x x x x x x x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CEFEPIME

Side effects:44
Source:FDA Structured Product Label

CEFEPIME HYDROCHLORIDE / MAXIPIME

Side effects:44
Source:FDA

CEFEPIME HYDROCHLORIDE / MAXIPIME

Side effects:45
Source:FDA

Cefepime Hydrochloride / Maxipime

Side effects:45
Source:FDA

CEFEPIME

Side effects:46
Source:FDA Structured Product Label

CEFEPIME

Side effects:46
Source:FDA Structured Product Label

CEFEPIME

Side effects:47
Source:FDA Structured Product Label

CEFEPIME

Side effects:46
Source:FDA Structured Product Label

CEFEPIME

Side effects:47
Source:FDA Structured Product Label

CEFEPIME

Side effects:47
Source:FDA Structured Product Label

CEFEPIME

Side effects:49
Source:FDA Structured Product Label

CEFEPIME

Side effects:50
Source:FDA Structured Product Label

Cefepime hydrochloride / APPROVED NAME:

Side effects:53
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label